Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancer

• Main Authors: Hayato Yokota (Author), Ruriko Asahi (Author), Yumiko Akamine (Author), Mizuki Kobayashi (Author), Hiyu Wakabayashi (Author), Sho Sakamoto (Author), Yuji Okuda (Author), Kazuhiro Sato (Author), Katsutoshi Nakayama (Author), Masafumi Kikuchi (Author)
• Format: Book
• Published: BMC, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Anamorelin, a drug to treat cancer cachexia, binds to ghrelin receptors and improves body weight and appetite. In clinical trials in Japan, patients experienced a 10.7% frequency of stimulant conduction system depression as a severe side effect. Although rare, anamorelin sometime...